2. Academic Validation
  3. Protein Phosphatase-1 Regulates Expression of Neuregulin-1

Protein Phosphatase-1 Regulates Expression of Neuregulin-1

  • Biology (Basel). 2016 Dec 2;5(4):49. doi: 10.3390/biology5040049.
Tatiana Ammosova 1 2 3,  Kareem Washington 4,  Jamie Rotimi 5,  Namita Kumari 6,  Kahli A Smith 7,  Xiaomei Niu 8,  Marina Jerebtsova 9,  Sergei Nekhai 10 11 12
Affiliations

Affiliations

  • 1 Center for Sickle Cell Disease, Howard University, Washington, DC 20059, USA. tatiana.ammosova@howard.edu.
  • 2 Department of Medicine, Howard University, Washington, DC 20059, USA. tatiana.ammosova@howard.edu.
  • 3 Yakut Science Center for Complex Medical Problems, Yakutsk 677019, Russia. tatiana.ammosova@howard.edu.
  • 4 Department of Human Genetics, Howard University, Washington, DC 20059, USA. kareem.washington@howard.edu.
  • 5 Center for Sickle Cell Disease, Howard University, Washington, DC 20059, USA. jerotimi@gmail.com.
  • 6 Center for Sickle Cell Disease, Howard University, Washington, DC 20059, USA. namita.kumari@howard.edu.
  • 7 Center for Sickle Cell Disease, Howard University, Washington, DC 20059, USA. kasmith8403@aol.com.
  • 8 Center for Sickle Cell Disease, Howard University, Washington, DC 20059, USA. xniu@howard.edu.
  • 9 Department of Microbiology, Howard University, Washington, DC 20059, USA. marina.jerebtsova@howard.edu.
  • 10 Center for Sickle Cell Disease, Howard University, Washington, DC 20059, USA. snekhai@howard.edu.
  • 11 Department of Medicine, Howard University, Washington, DC 20059, USA. snekhai@howard.edu.
  • 12 Department of Microbiology, Howard University, Washington, DC 20059, USA. snekhai@howard.edu.
PMID: 27918433 DOI: 10.3390/biology5040049
Abstract

Protein Phosphatase 1 (PP1), a cellular serine/threonine Phosphatase, is targeted to cellular promoters by its major regulatory subunits, PP1 nuclear targeting subunit, nuclear inhibitor of PP1 (NIPP1) and RepoMan. PP1 is also targeted to RNA polymerase II (RNAPII) by NIPP1 where it can dephosphorylate RNAPII and cycle-dependent kinase 9 (CDK9). Here, we show that treatment of cells with a small molecule activator of PP1 increases the abundance of a neuregulin-1 (NRG-1)-derived peptide. NRG-1 mRNA and protein levels were increased in the cells stably or transiently expressing mutant NIPP1 (mNIPP1) that does not bind PP1, but not in the cells expressing NIPP1. Expression of mNIPP1 also activated the NRG-1 promoter in an NF-κB-dependent manner. Analysis of extracts from mNIPP1 expressing cells by glycerol gradient centrifugation showed a redistribution of PP1 and CDK9 between large and small molecular weight complexes, and increased CDK9 Thr-186 phosphorylation. This correlated with the increased CDK9 activity. Further, RNAPII co-precipitated with mNIPP1, and phosphorylation of RNAPII C-terminal domain (CTD) Ser-2 residues was greater in cells expressing mNIPP1. In mNIPP1 expressing cells, okadaic acid, a cell-permeable inhibitor of PP1, did not increase Ser-2 CTD phosphorylation inhibited by flavopiridol, in contrast to the NIPP1 expressing cells, suggesting that PP1 was no longer involved in RNAPII dephosphorylation. Finally, media conditioned with mNIPP1 cells induced the proliferation of wild type 84-31 cells, consistent with a role of neuregulin-1 as a growth promoting factor. Our study indicates that deregulation of PP1/NIPP1 holoenzyme activates NRG-1 expression through RNAPII and CDK9 phosphorylation in a NF-κB dependent manner.

Keywords

CDK9; NIPP1; neuregulin-1 transcription; protein phosphatase-1.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-130514
    PP1 Activator
    HIV; CDK